HL Deb 26 March 2001 vol 624 cc4-5WA
Lord Faulkner of Worcester

asked Her Majesty's Government:

How they intend to build on the strategic approach to hepatitis C. [HL1383]

Lord Hunt of Kings Heath

The Department of Health is setting up a steering group with the following terms of referenceTo oversee development of the Department's strategic approach to hepatitis C by bringing together issues relating to prevention, control and treatment and to produce a document within the year, for consultation with the NHS, professional bodies and the voluntary and community sectors. The proposed membership of the group is as follows.

STEERING GROUP MEMBERSHIP

Chairman

Professor Howard Thomas, Imperial College School of Medicine, London and Chairman, Advisory Group on Hepatitis

Members

Jim Camp, Needle Exchange Forum

Ms Hannah Cinamon, Health Promotion England Professor Chris Day, Medical School, Newcastle University

Ms Jo Guy, Hepatology Nurse Specialist, Southampton General Hospital

Dr Paul Hatton, Consultant in Communicable Disease Control, Leeds Health Authority and Member, Advisory Group on Hepatitis

Ms Lorraine Hewitt, Action on Hepatitis C and Member, Advisory Council on the Misuse of Drugs

Nigel Hughes, British Liver Trust

Dr Will Irving, Department of Microbiology, University of Nottingham and Member, Advisory Group on Hepatitis

Grant McNally, National Drug Users Development Agency

Dr Mary Ramsay, Public Health Laboratory Service Communicable Disease Surveillance Centre

Professor Gerry Stimson, Centre for Research on Drugs and Medicine, Imperial College School of Medicine, London

Professor John Strang, Director of the National Addiction Centre, Maudsley Hospital, London and Member of the Advisory Council on the Misuse of Drugs

Ms Monique Tomlinson, Mainliners

Dr Martyn Wake, General Practitioner, South West London

Forward to